Xenogeneic human p53 DNA vaccination by electroporation breaks immune tolerance to control murine tumors expressing mouse p53.
about
DNA vaccine for cancer immunotherapyCSPG4: a prototype oncoantigen for translational immunotherapy studies.Toll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract leading to tumor control through IFNγDNA vaccines, electroporation and their applications in cancer treatmentUsing the E4orf6-Based E3 Ubiquitin Ligase as a Tool To Analyze the Evolution of Adenoviruses.Direct T cell activation via CD40 ligand generates high avidity CD8+ T cells capable of breaking immunological tolerance for the control of tumors.Xenogene vaccination in the therapy of cancer.Vectors and strategies for nonviral cancer gene therapy.Review on the immunotherapy strategies against metastatic colorectal carcinoma.Messenger RNA vaccine based on recombinant MS2 virus-like particles against prostate cancer.DNA vaccine elicits an efficient antitumor response by targeting the mutant Kras in a transgenic mouse lung cancer model.Intranasal Immunization with DnaK Protein Induces Protective Mucosal Immunity against Tuberculosis in CD4-Depleted Mice.Production of a bioactive recombinant chicken matrix metalloproteinase-11 peptide in Escherichia coli.Post-operative unadjuvanted therapeutic xenovaccination with chicken whole embryo vaccine suppresses distant micrometastases and prolongs survival in a murine Lewis lung carcinoma model.
P2860
Q28080919-90C31503-6D16-495C-BCDD-8FE70AE65B82Q33862585-72466EE4-7935-4143-B772-7E3DE6C4987AQ34438411-D7428DFC-FC38-4C6F-8993-3846CEA1CB99Q36256459-F14BB368-39C4-45D4-9274-F45C89D49F9BQ37174450-E592DB9B-7705-4FAE-B72D-F8655BC89252Q37659577-F2654A6A-8318-4F73-8AA1-F18B413931F5Q38229368-E922DC2A-F23C-4B07-A801-11F62E86C061Q38694798-7A7D4A46-B9F8-4096-A0A5-6A6295F2C411Q38948909-AF19F792-C845-4E3C-880B-77896C9E15A4Q39084400-A9F82951-FF85-481B-9428-A630820D9475Q42202805-F8AC899D-76C1-418A-B0EA-9912B43D0429Q50249835-3F304F72-F912-4830-ACCB-2E318FE5B239Q51702830-8CDD307E-381C-4B68-9CC0-BDDAA75E1EA3Q52649737-93D8EBCC-6988-447E-B33A-8BEA55A838C7
P2860
Xenogeneic human p53 DNA vaccination by electroporation breaks immune tolerance to control murine tumors expressing mouse p53.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Xenogeneic human p53 DNA vacci ...... e tumors expressing mouse p53.
@ast
Xenogeneic human p53 DNA vacci ...... e tumors expressing mouse p53.
@en
Xenogeneic human p53 DNA vacci ...... e tumors expressing mouse p53.
@nl
type
label
Xenogeneic human p53 DNA vacci ...... e tumors expressing mouse p53.
@ast
Xenogeneic human p53 DNA vacci ...... e tumors expressing mouse p53.
@en
Xenogeneic human p53 DNA vacci ...... e tumors expressing mouse p53.
@nl
prefLabel
Xenogeneic human p53 DNA vacci ...... e tumors expressing mouse p53.
@ast
Xenogeneic human p53 DNA vacci ...... e tumors expressing mouse p53.
@en
Xenogeneic human p53 DNA vacci ...... e tumors expressing mouse p53.
@nl
P2093
P2860
P1433
P1476
Xenogeneic human p53 DNA vacci ...... e tumors expressing mouse p53.
@en
P2093
Chien-Fu Hung
Janson Trieu
Liangmei He
Ruey-Shyang Soong
Sung Yong Lee
Ya-Chea Tsai
P2860
P304
P356
10.1371/JOURNAL.PONE.0056912
P407
P577
2013-02-15T00:00:00Z